Bionik Laboratories Corp. (BNKL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.98 Million USD | 199.68% |
| 2022 | -1.99 Million USD | -164.03% |
| 2021 | 3.1 Million USD | 1728.94% |
| 2020 | -190.91 Thousand USD | 57.27% |
| 2019 | -446.77 Thousand USD | 1.99% |
| 2018 | -455.83 Thousand USD | -122.33% |
| 2017 | 2.04 Million USD | 137.92% |
| 2016 | -5.38 Million USD | -618.52% |
| 2015 | 1.03 Million USD | 23571.62% |
| 2014 | -4422.00 USD | -103.89% |
| 2013 | 113.73 Thousand USD | 1861.98% |
| 2012 | -6455.00 USD | -247.98% |
| 2011 | -1855.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - USD | -100.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 Q3 | 1.17 Million USD | 84.33% |
| 2023 Q4 | 1.98 Million USD | 68.53% |
| 2023 FY | 1.98 Million USD | 199.68% |
| 2023 Q1 | -825.31 Thousand USD | 58.56% |
| 2023 Q2 | 638.95 Thousand USD | 177.42% |
| 2022 Q2 | 3.71 Million USD | 10.35% |
| 2022 Q3 | 5.37 Million USD | 44.48% |
| 2022 Q4 | -1.99 Million USD | -137.08% |
| 2022 FY | -1.99 Million USD | -164.03% |
| 2022 Q1 | 3.36 Million USD | 8.31% |
| 2021 Q1 | 1.5 Million USD | 890.7% |
| 2021 Q3 | 3.4 Million USD | 18.57% |
| 2021 Q4 | 3.1 Million USD | -8.68% |
| 2021 FY | 3.1 Million USD | 1728.94% |
| 2021 Q2 | 2.87 Million USD | 90.27% |
| 2020 FY | -190.91 Thousand USD | 57.27% |
| 2020 Q1 | 924.41 Thousand USD | 306.91% |
| 2020 Q2 | -4.6 Million USD | -598.12% |
| 2020 Q3 | -1.82 Million USD | 60.45% |
| 2020 Q4 | -190.91 Thousand USD | 89.52% |
| 2019 Q2 | -305.75 Thousand USD | -113.97% |
| 2019 FY | -446.77 Thousand USD | 1.99% |
| 2019 Q4 | -446.77 Thousand USD | -114.12% |
| 2019 Q3 | 3.16 Million USD | 1134.72% |
| 2019 Q1 | 2.18 Million USD | 580.03% |
| 2018 Q1 | 2.3 Million USD | 13.17% |
| 2018 FY | -455.83 Thousand USD | -122.33% |
| 2018 Q4 | -455.83 Thousand USD | -106.98% |
| 2018 Q3 | 6.53 Million USD | 66.55% |
| 2018 Q2 | 3.92 Million USD | 69.78% |
| 2017 Q1 | -2.19 Million USD | 59.13% |
| 2017 Q4 | 2.04 Million USD | 322.69% |
| 2017 FY | 2.04 Million USD | 137.92% |
| 2017 Q2 | -1.1 Million USD | 49.85% |
| 2017 Q3 | 482.85 Thousand USD | 143.77% |
| 2016 Q1 | -9.07 Million USD | -48.21% |
| 2016 FY | -5.38 Million USD | -618.52% |
| 2016 Q2 | -7.85 Million USD | 13.43% |
| 2016 Q4 | -5.38 Million USD | 18.67% |
| 2016 Q3 | -6.61 Million USD | 15.8% |
| 2015 Q2 | -8787.00 USD | -19.84% |
| 2015 Q1 | -7332.00 USD | -24.76% |
| 2015 Q4 | -6.12 Million USD | -188829.92% |
| 2015 FY | 1.03 Million USD | 23571.62% |
| 2015 Q3 | -3242.00 USD | 63.1% |
| 2014 Q4 | -5877.00 USD | -32.9% |
| 2014 Q2 | -2967.00 USD | -96.23% |
| 2014 Q1 | -1512.00 USD | -166.67% |
| 2014 FY | -4422.00 USD | -103.89% |
| 2014 Q3 | -4422.00 USD | -49.04% |
| 2013 Q4 | -567.00 USD | 88.54% |
| 2013 Q1 | -4427.00 USD | 4.3% |
| 2013 Q2 | -5568.00 USD | -25.77% |
| 2013 Q3 | -4949.00 USD | 11.12% |
| 2013 FY | 113.73 Thousand USD | 1861.98% |
| 2012 Q3 | -6455.00 USD | -217.2% |
| 2012 Q2 | -2035.00 USD | 0.0% |
| 2012 FY | -6455.00 USD | -247.98% |
| 2012 Q4 | -4626.00 USD | 28.33% |
| 2011 FY | -1855.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | -469.62 Thousand USD | 522.659% |
| Arem Pacific Corporation | 181.02 Thousand USD | -996.505% |
| Assisted 4 Living, Inc. | -199.71 Thousand USD | 1093.894% |
| BioCorRx Inc. | 5.56 Million USD | 64.361% |
| Banyan Corp. | 3.6 Million USD | 44.964% |
| Clearday, Inc. | 44.86 Million USD | 95.576% |
| Dental Patient Care America, Inc. | -1.99 Million USD | 199.396% |
| Quantum Medical Transport, Inc. | 1065.27 USD | -186230.789% |
| Empower Clinics Inc. | 2.29 Million USD | 13.656% |
| First Choice Healthcare Solutions, Inc. | 23.22 Million USD | 91.455% |
| Selectis Health, Inc. | 35.76 Million USD | 94.45% |
| Ethema Health Corporation | 14.51 Million USD | 86.325% |
| HealthLynked Corp. | 1.72 Million USD | -14.967% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 13.79 Million USD | 85.61% |
| JRSIS Health Care Corporation | 911.83 Thousand USD | -117.685% |
| Comjoyful International Company | -28.32 Thousand USD | 7106.693% |
| Medical Facilities Corporation | 92.22 Million USD | 97.848% |
| MedSmart Group Inc. | 659.56 Thousand USD | -200.947% |
| North America Frac Sand, Inc. | 265.41 Thousand USD | -647.858% |
| Nova Leap Health Corp. | -686.52 Thousand USD | 389.126% |
| Nexteligent Holdings, Inc. | 1.83 Million USD | -7.979% |
| PAO Group, Inc. | 639.37 Thousand USD | -210.448% |
| Primemd Inc. | 4.54 Million USD | 56.314% |
| Raffles Medical Group Ltd | -194.49 Million USD | 101.021% |
| Ryman Healthcare Limited | 1.51 Billion USD | 99.869% |
| Stem Cell Authority, Ltd. | 15.00 USD | -13232740.0% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.24 Million USD | -59.673% |
| Mycotopia Therapies, Inc. | 811.51 Thousand USD | -144.595% |
| U.S. NeuroSurgical Holdings, Inc. | -381 Thousand USD | 620.978% |
| Veltex Corporation | 2.17 Million USD | 8.924% |
| World Financial Holding Group | 98.11 Thousand USD | -1923.102% |
| Xcelerate Inc. | 1.18 Million USD | -67.821% |